Sequential therapies with intravenous cyclophosphamide and oral mycophenolate mofetil or azathioprine are efficacious and safe in proliferative lupus nephritis - Comment

被引：0
|
作者：
Boumpas, DT [1 ]
机构：
[1] Univ Crete, Sch Med, Div Rheumatol Clin Immunol & Allergy, Dept Internal Med, Iraklion 71500, Greece
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2004年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [1] Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide
    Contreras, G
    Tozman, E
    Nahar, N
    Metz, D
    [J]. LUPUS, 2005, 14 : S33 - S38
  • [2] Lupus nephritis: Sequential therapy with short-term intravenous cyclophosphamide followed by maintenance oral mycophenolate mofetil or oral azathioprine is more efficacious and safer than long-term intravenous cyclophosphamide
    Contreras, G
    Pardo, V
    Leclercq, B
    Lenz, O
    ONan, P
    Tozman, E
    Roth, D
    Rogers, T
    Iqbal, K
    Tawakol, J
    Cuellar, M
    Khan, T
    Schulman, I
    Vemuri, N
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 38A - 38A
  • [3] Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis
    Killen, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07): : 764 - 765
  • [4] Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
    Ginzler, EM
    Dooley, MA
    Aranow, C
    Kim, MY
    Buyon, J
    Merrill, JT
    Petri, M
    Gilkeson, GS
    Wallace, DJ
    Weisman, MH
    Appel, GB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2219 - 2228
  • [5] Mycophenolate mofetil in lupus nephritis refractary to intravenous cyclophosphamide
    Daza, Leonel
    Perez, Salvador
    Velasco, Ulises
    Hernandez, Martha
    [J]. REUMATOLOGIA CLINICA, 2006, 2 (05): : 247 - 250
  • [6] Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis - Reply
    Ginzler, EM
    Dooley, MA
    Kim, MY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07): : 765 - 765
  • [7] Comment on: Efficacy and Safety of Mycophenolate Mofetil versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis
    Ziaie, Shadi
    Moradi, Omid
    Saffaei, Ali
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2019, 13 (05) : 347 - 347
  • [8] Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide
    Glicklich, D
    Acharya, A
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) : 318 - 322
  • [9] Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis
    Gadakchi, Leyla
    Hajialilo, Mehrzad
    Nakhjavani, Mohammad-Reza
    Azar, Sima Abedi
    Kolahi, Sousan
    Gojazadeh, Morteza
    Ebrahimi, Ali-asghar
    Mahdavi, Aida Malek
    Noshad, Hamid
    Khabbazi, Alireza
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 288 - 292
  • [10] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    Eid M. El-Shafey
    Said H. Abdou
    Mohamed M. Shareef
    [J]. Clinical and Experimental Nephrology, 2010, 14 : 214 - 221
12345